Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Events

08 Dec 2026 - 10 Dec 2026
25 Jan 2027 - 28 Jan 2027

First U.S. Procedures Successfully Completed With New GERD Implant

By HospiMedica International staff writers
Posted on 09 Nov 2026

Conventional surgeries that encircle the esophagus to treat gastroesophageal reflux disease (GERD) can be associated with swallowing difficulties, gas bloating, and an inability to belch or vomit. More...

Clinicians continue to seek surgical approaches that correct the anatomical cause of reflux while preserving more natural swallowing function. A new device now offers a method designed to restore the natural anti-reflux barrier without encircling the esophagus.

Implantica’s RefluxStop is an implant designed for the treatment of GERD, and its first commercial procedures in the United States were completed on November 4, 2026, at the University of Southern California (USC) in Los Angeles. The cases represented the initial U.S. use of the system in clinical practice. The milestone expands availability of the therapy to American centers.

RefluxStop is designed to address the root cause of reflux by restoring the body’s natural anti‑reflux barrier. The implant aims to restore and maintain the lower esophageal sphincter (LES) in its natural anatomical position without encircling or applying pressure to the food passageway. By avoiding wrapping or constricting the esophageal sphincter, the approach differs from conventional anti‑reflux procedures that are often linked to adverse effects such as dysphagia, inability to belch or vomit, and gas bloating.

RefluxStop is U.S. Food and Drug Administration (FDA) approved and CE‑marked for the treatment of GERD. Long‑term five‑year clinical outcomes published in peer‑reviewed journals support that a significant portion of patients can achieve clinically meaningful results with minimal risks when the device is used according to its indications for use. Commercial performance from multiple centers is reported to align with study findings and indicates effective GERD control without esophageal constriction and with fewer side effects.

The device is indicated to treat acid and non‑acid reflux in patients diagnosed with GERD. Its intended action is to maintain the gastroesophageal junction in a defined intra‑abdominal position to permit natural physiological function of the LES, thereby reducing or eliminating reflux. A dedicated deployment tool is indicated for patients diagnosed with GERD by abnormal impedance‑pH and/or pH testing who are candidates for RefluxStop implantation.

“With RefluxStop we now have a solution that addresses a significant unmet medical need - not only for the approximately 40% of GERD patients who respond inadequately to medication, but also for the more than one-third of sufferers with swallowing difficulties who have no well working treatment today. For decades, we have sought a treatment that provides effective reflux control without compromising patient's natural swallowing,” said Dr. John C. Lipham, Chief of the Division of Upper GI and General Surgery, Keck School of Medicine of USC and Past President and Co‑founder of the American Foregut Society.

Related Links
Implantica


Gold Member
12-Channel ECG
CM1200B
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Surgical System
Stealth AXiS
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Medical Imaging

view channel
Image: A new automated approach could help predict which patients with dystonia will benefit from deep brain stimulation before surgery (Image Credit: Adobe Stock)

AI Uses Routine MRI to Predict Deep Brain Stimulation Response in Dystonia

Dystonia is a debilitating neurological movement disorder characterized by involuntary muscle contractions that cause abnormal movements and postures. Deep brain stimulation (DBS) is one of the few treatments... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.